Scholar Rock Holding Corp (SRRK)
Healthcare
Biotechnology
47.30 $
-3.5%
vs. previous close
Closing price · As of: 31. Jul 2026
Scholar Rock Holding Corp (SRRK) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -82 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -33 | -32 | -37 | -50 | -49 | -52 | -50 | -79 | -77 | -69 | -75 | -82 | -303 | |
| 0.7 | 0.7 | 0.7 | 0.6 | 0.5 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.3 | 1.6 | |
| 6.8 | 7.2 | 7.0 | 8.2 | 9.3 | 9.7 | 9.5 | 13 | 24 | 18 | 19 | 18 | 80 | |
| 6.8 | – | – | – | – | – | – | – | – | – | – | – | – | |
| -2.9 | 2.1 | 1.3 | -1.5 | -0.5 | 1.4 | 7.2 | -18 | 8.3 | 18 | -5.7 | 0.1 | 20 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.3 | 0.2 | 0.1 | 0.0 | 0.1 | 0.4 | |
| -15 | -8.5 | -25 | 33 | 51 | 35 | -195 | 35 | 85 | 60 | 39 | -5.3 | 179 | |
| 4.7 | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | 0.0 | – | -0.9 | 0.0 | 50 | 0.0 | 94 | 144 | |
| 4.7 | 0.3 | 97 | 6.5 | 0.0 | 0.2 | 346 | 4.2 | 6.5 | 144 | 73 | 194 | 418 | |
| -43 | -40 | 34 | -9.9 | 1.4 | -17 | 101 | -40 | 15 | 135 | 37 | 107 | 294 | |
| -33 | -32 | -37 | -50 | -49 | -52 | -50 | -79 | -77 | -69 | -76 | -82 | -304 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.